Skip to main content

Animations

MJFF Publications

701 - 710 of 6564 Results
Title
Year
  • Year
  • 2026
  • 2026
  • 2026
  • 2026
  • 2026
  • 2024
  • 2023
  • 2023
  • 2026
  • 2023
  • Summary Details
    OPEN
    Title: Targeting lysosomal pH restores mitochondrial quality control in GBA1-mutant Parkinson’s disease
    Journal Name: Translational Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s40035-026-00559-z
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Understanding the genetic imperfections of Lewy body dementia
    Journal Name: Molecular Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13024-026-00961-1
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Engineering functional ventral midbrain dopaminergic neurons in human organoids through WNT modulation and bioreactor culture
    Journal Name: Molecular Psychiatry
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41380-026-03667-4
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Leucine-rich repeat kinase 2 impairs the release sites of Parkinson’s disease vulnerable dopamine axons
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-026-75194-3
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Ischemic Stroke Increases Protein Expression of the Folate Receptor and One-carbon Enzymes in Brain Tissue From Male and Female Patients
    Journal Name: Translational Stroke Research
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s12975-026-01479-w
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Synapsin E-domain is essential for α-synuclein function
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.7554/elife.89687.3
    Citation Count: 14
  • Summary Details
    OPEN
    Title: Scaling of an antibody validation procedure enables quantification of antibody performance in major research applications
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.7554/elife.91645.2
    Citation Count: 47
  • Summary Details
    OPEN
    Title: Cell-free RNA signatures predict Alzheimer’s disease
    Journal Name: iScience
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.isci.2023.108534
    Citation Count: 13
  • Summary Details
    OPEN
    Title: The LRRK2 G2019S variant rewires Rab GTPase phosphorylation after lysosomal damage and promotes cell death in human macrophages
    Journal Name: Journal of Cell Science
    Publisher: The Company of Biologists
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1242/jcs.265083
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Development and validation of an expanded antibody toolset that captures alpha-synuclein pathological diversity in Lewy body diseases
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-023-00604-y
    Citation Count: 53
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.